Ballerup, 7 November 2024 -- With the announcement of three new members to the Global Leadership Team and a new head of Global Communications, LEO Pharma is taking another important step towards further professionalizing the organization and realizing its strategy to become the leader in medical dermatology.

Kristian Sibilitz will take up the position as Executive Vice President, Technical Development and Supply and member of the Global Leadership Team on 1 December 2024. He replaces Sven Hauptmann, who has decided to resign from LEO Pharma to join a Swiss company. Sven Hauptmann will leave by 30 November 2024.

Kristian Sibilitz brings extensive experience to LEO Pharma, having spent over 19 years at H. Lundbeck A/S in various leadership roles within Product Development and Supply. Currently, he is the Senior Vice President of Pharmaceutical Production and Supply Chain, overseeing manufacturing, packaging, supply chain planning, and global distribution. A Danish citizen, Kristian holds a Master of Science in Supply Chain Management from the Technical University of Denmark, DTU.

CEO, Christophe Bourdon said: “We are pleased to welcome Kristian to the Global Leadership Team, where his extensive expertise and strong track record will be highly valued. At the same time, I would like to extend my sincere gratitude to Sven for his remarkable efforts in delivering safe and innovative products to patients, which have been unparalleled.”

In addition, Jean Monin, EVP of thrombosis, and Anne Jensen, VP, who leads LEO Pharma's strategy team, will also join the Global Leadership Team.

CEO Christophe Bourdon said, “I am delighted to welcome Jean and Anne to the Global Leadership Team. Jean has demonstrated proven success as a commercial leader, driving excellent results across the Thrombosis Global Business Unit in recent quarters. With Jean’s commercial expertise and Anne’s achievements in sharpening LEO Pharma’s strategy, they are both well-positioned to enhance our strategic execution and optimize LEO Pharma’s ability to capitalize on both present and future opportunities.”

Additionally, Anders Monrad Rendtorff will join LEO Pharma as Senior Vice President for Global Communications. Anders Monrad Rendtorff brings extensive experience to LEO Pharma, having worked for large, listed companies such as Coloplast and Vestas.